TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Nexus Industrial REIT (“Nexus” or the “REIT”) (TSX: NXR.UN) announced today that it intends to release its financial results for the fourth quarter and year ended December 31, 2025, before the opening of the TSX on Friday, March 6, 2026. Management of the REIT will host a conference call at 10:00 AM Eastern Standard Time on Friday March 6, 2026, to review the financial results and operations. To participate in the conference call, please dial 1-647-846-8414 or 1-833-752-3601 (toll free in Canada and the US) at least five minutes prior to the start time and ask to join the Nexus Industrial REIT conference call. A recording of the conference call will be available until April 6, 2026. To access the recording, please dial 1-412-317-0088 or 1-855-669-9658 (toll free in Canada and...

DENVER, Jan. 08, 2026 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (NYSE: NBHC) expects to report its fourth quarter and full year 2025 financial results after the markets close on Tuesday, January 27, 2026. Management will host a conference call to review the results at 11:00 a.m. Eastern Time on Wednesday, January 28, 2026. The call may also include discussion of company developments, forward-looking statements and other material information about business and financial matters. Interested parties may listen to this call by dialing (800) 330-6710 using the participant passcode of 6983606 and asking for the NBHC Q4 2025 Earnings Call. A recording of the call will be available approximately four hours after the call’s completion on the company’s website at www.nationalbankholdings.com by visiting the investor relations...

International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market Opportunity for Tilray Medical Expansion into the U.S. Strong Financial Position with $292 Million in Cash and Marketable Securities1 and ~$30 Million Net Cash NEW YORK and LONDON and LEAMINGTON, Ontario, Jan. 08, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today reported financial results for its second fiscal quarter ended November 30, 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise...

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.Earnings webcast details:• Location: https://investor.resmed.com• Date: Thursday, January 29, 2026• Time: 1:30 p.m. PST / 4:30 p.m. EST• International: London, Thursday, January 29, 2026, 9:30 p.m. GMT    Sydney, Friday, January 30, 2026, 8:30 a.m. AEDTPlease note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A...

— Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years– BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported preliminary, unaudited total revenue of $726.4 million for the year ended December 31, 2025, compared with $701.0 million for the year ended December 31, 2024. The company also repurchased 2.0 million shares of its common stock during the fourth quarter. “We closed 2025 having achieved another year of solid execution and meaningful progress advancing our 5×30 strategic priorities, leaving us well-positioned for sustainable, long-term success,” said Frank D. Lee,...

LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) — AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced financial and operational results for the second quarter ended November 30, 2025 (2Q26). Financial Highlights (Quarter Ended November 30, 2025)Net sales increased to $8.1 million, compared to $7.7 million in the prior year period, an increase of 5.2% Gross profit of $5.5 million, or 68.1% of sales, compared to $5.5 million, or 71.1% in the prior year period Operating expenses declined to $4.6 million, or 57.0% of net sales compared to $4.8 million, or 62.4% of net sales in the prior year period Net income increased to $704,833, compared to $633,706...

MINNEAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the first quarter of fiscal 2026. First quarter fiscal 2026 financial and operating highlights include (with growth rates on a fiscal quarter year-over-year basis):Consolidated net sales increased 9.2% to a quarterly record of $23,309,000 ZERUST® industrial net sales increased 6.9% to a quarterly record of $14,923,000 ZERUST® oil and gas net sales increased 58.1% to a first quarter record of $2,394,000 Natur-Tec® product net sales increased 2.2% to a quarterly record of $5,993,000 NTIC China net sales increased 23.5% to a quarterly record of $4,935,000 Gross...

DENVER, Jan. 08, 2026 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen weeks ended November 29, 2025. First Quarter Summary:(1)Net sales of $340.2 million versus $341.3 million Net income of $25.3 million versus $38.1 million Earnings per diluted share (“EPS”) of $0.26 versus $0.38 Adjusted Diluted EPS(2) of $0.39 versus $0.49 Adjusted EBITDA(3) of $55.6 million versus $70.1 millionReaffirm Fiscal Year 2026(4) Outlook:Net sales expected to range between -2% and +2% year-over-year Gross margins expected to decline between 100 and 150 basis points year-over-year Adjusted EBITDA expected to range between -4% and +1% year-over-year“Our first quarter financial performance came...

Strong Performance Delivers Sales Growth, Margin Expansion and EPS ImprovementDelivered Net Sales of $1.1B, an Increase of 20% Compared to the Prior Year Delivered Operating Profit of $160M, Up 20% Compared to the Prior Year; Grew Adjusted Operating Profit to $196M, Up 24% Compared to the Prior Year Delivered Diluted EPS of $3.82, Up 14% Compared to the Prior Year; Grew Adjusted Diluted EPS to $4.69, Up 18% Compared to the Prior YearATLANTA, Jan. 08, 2026 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI), (“Acuity”), a market-leading industrial technology company, delivered net sales of $1.1 billion in the first quarter of fiscal 2026 ended November 30, 2025, an increase of $192.1 million, or 20.2 percent, compared to the prior year. “We delivered strong performance in our first quarter of fiscal 2026,” stated...

Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET). Total 2025 revenues are estimated to be approximately US$376 million*, exceeding the upwardly revised guidance range of US$365 to US$375 million provided in November 2025 and representing approximately 27% growth versus 2024. This strong performance reflects continued growth of RUCONEST® and rising demand for Joenja®, driven primarily by patient uptake in the U.S. and supported by ongoing geographic expansion. Full-year 2025 operating expenses are expected to be within the previously communicated range of US$304 to US$308 million, underscoring...